Pre-Conference Day
Wednesday, July 10 2024

FOCUS DAY TRACK

Bioconvergence Enabling Microbiome Platforms

Synopsis

Join this targeted focus day as we facilitate the convergence of biological sciences, data analytics and engineering principals to accelerate R&D into viable drug candidates

Assessing Effective Adoption of AI/ML to Gain Efficiencies & Refine Quality

8:30 am Shaping Our Microbiome for Lifelong Health

  • Andrew Bartko Executive Director - Center of Microbiome Innovation, UC San Diego

Synopsis

Download the Full Event Guide to see session details

9:00 am Multi-Level Analysis of the Gut–Brain Axis Shows Autism Spectrum Disorder-Associated Molecular & Microbial Profiles

Synopsis

Download the Full Event Guide to see session details

Exploring Microbiome Analytical Tools

9:30 am Panel Discussion: Unravelling Barriers to Adoption of AI/ML in Microbiome Research

  • James Morton Consultant, Simons Foundation
  • Andrew Bartko Executive Director - Center of Microbiome Innovation, UC San Diego
  • Giulio Pasinetti Director - Center for Molecular Integrative Neuroresilience, Icahn School of Medicine, Mount Sinai

Synopsis

Download the Full Event Guide to see session details

DEEP-DIVE NETWORKING WORKSHOPS

Strategic Intelligence for Portfolio Planning & Network Building

Synopsis

Data and discussions bringing you the most current microbiome ecosystem updates, paired with working sessions to strengthen your connections with key opinion leaders and field experts 

8:30 am Workshop A – Defining a Strategic Roadmap for Transitioning from Successful Clinical Trials to Regulatory Approval: Phase Appropriate Regulatory Strategy

  • Ken Blount Chief Scientific Officer, Rebiotix, A Ferring Company

Synopsis

Download the Full Event Guide to see session details

Featuring a Case Study: Regulatory Considerations for Microbiome-Based Therapies for Pediatric Use

  • Ellen Turner Medical Officer, US Food & Drug Administration (FDA)

Synopsis

Download the Full Event Guide to see session details

10:30 am Morning Break

11:00 am Interactive Working Group Discussion: Navigating Analytical Gaps: Fostering Innovation for Robust Assessment of Microbiome Drug Efficacy in Clinical Settings

  • Dylan Lawrence Senior Scientist, Washington University in St. Louis, Pfizer

Synopsis

Download the Full Event Guide to see session details

12:00 pm Leveraging Spatial Methods & Analysis for Microbiome-Based Biological Insights

  • Mariia Taguer Scientist, Microbiology & Bioengineering, Merck & Co

Synopsis

Download the Full Event Guide to see session details

11:00 am Workshop B – Navigating Geographic and Regulatory Variances in Microbiome Drug Development

Synopsis

Download the Full Event Guide to see session details

12:30 pm Lunch & Networking

1:30 pm Role of the Immune T Regulatory Cells in Mood Disorders and Alzheimer’s Disease Phenotype as a Therapeutic Target in Altered Gut-Brain Axis Cross-Talking

  • Giulio Pasinetti Director - Center for Molecular Integrative Neuroresilience, Icahn School of Medicine, Mount Sinai

Synopsis

Download the Full Event Guide to see session details

2:00 pm Single-Cell Genomics for Resolution of Conserved Bacterial Genes & Mobile Genetic Elements of the Human Intestinal Microbiota Using Flow Cytometry

  • Dylan Lawrence Senior Scientist, Washington University in St. Louis, Pfizer

Synopsis

Download the Full Event Guide to see session details

Uncovering Novel Platform Development to Refine Platform Technologies

2:30 pm Innovative Platform Development: Validating a Novel Platform in Preclinical Models of the Microbiome in Differential Physiological States

Synopsis

Download the Full Event Guide to see session details

1:30 pm Workshop C – Microbiome Macroeconomics: Analysing Industry Trends to Inform Microbiome Drug Development Strategy

Synopsis

Download the Full Event Guide to see session details

Featuring a Case Study: Vertical Integration to Reduce Costs, Improve Turnaround Times, Increase Flexibility & Generate Revenue: A Biopharma Case Study

  • Nick Conley Vice President, Technology, Locus Biosciences

Synopsis

Download the Full Event Guide to see session details

3:30 pm Afternoon Break

The Microbiome Movement: Standardization & Probiotic Data Beyond Drug Development

4:00 pm Translating Preclinical Gut-Brain Axis Research into Clinical Trials Using Prebiotic Interventions

Synopsis

Download the Full Event Guide to see session details

4:30 pm The Use of a Novel Dual Pro- & Post- Biotic in Adults with IBS-D: Results from a Recent (Unpublished) RCT

Synopsis

Download the Full Event Guide to see session details

4:00 pm Workshop D – Market Engagement: Paving a Path to Commercially Successful Microbiome Drug Development

  • Olaf Larsen Senior Manager Science & Management Team & Professor , One Health Innovation, Athena Institute, Yakult Netherlands & Vrije Universiteit Amsterdam
  • Caleb Bell Venture Partner, Corundum Systems Biology
  • Colleen Acosta Chief Executive Officer, Freya Biosciences
  • James McIlroy Founder & Chief Executive Officer, EnteroBiotix

Synopsis

Download the Full Event Guide to see session details

Featuring a Case Study from Yakult Netherlands: Gut Microbiota Management: A One Health Business Case & Valorization Potential

  • Olaf Larsen Senior Manager Science & Management Team & Professor , One Health Innovation, Athena Institute, Yakult Netherlands & Vrije Universiteit Amsterdam

Synopsis

Download the Full Event Guide to see session details

5:30 pm End of Pre-Conference Day

2024 SPEAKERS
2024 EVENT GUIDE
DAY ONE